Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is Zoetis Stock Underperforming the Nasdaq?

Valued at a market cap of $67.6 billion, Zoetis Inc. (ZTS) is a global leader in animal health. The company develops, manufactures, and commercializes medicines, vaccines, diagnostics, biodevices, genetic tests, and precision animal health solutions for both livestock and companion animals. 

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Zoetis fits this criterion perfectly. With a diversified portfolio and strategic collaborations, Zoetis continues to expand its reach, driven by rising pet ownership, increased spending on animal care, and innovation in veterinary health.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.